vs

Side-by-side financial comparison of Phreesia, Inc. (PHR) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Phreesia, Inc. is the larger business by last-quarter revenue ($120.3M vs $87.2M, roughly 1.4× Schrodinger, Inc.). Schrodinger, Inc. runs the higher net margin — 37.3% vs 3.5%, a 33.7% gap on every dollar of revenue. On growth, Phreesia, Inc. posted the faster year-over-year revenue change (12.7% vs -1.2%). Phreesia, Inc. produced more free cash flow last quarter ($12.2M vs $-16.1M).

Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

PHR vs SDGR — Head-to-Head

Bigger by revenue
PHR
PHR
1.4× larger
PHR
$120.3M
$87.2M
SDGR
Growing faster (revenue YoY)
PHR
PHR
+13.9% gap
PHR
12.7%
-1.2%
SDGR
Higher net margin
SDGR
SDGR
33.7% more per $
SDGR
37.3%
3.5%
PHR
More free cash flow
PHR
PHR
$28.3M more FCF
PHR
$12.2M
$-16.1M
SDGR

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PHR
PHR
SDGR
SDGR
Revenue
$120.3M
$87.2M
Net Profit
$4.3M
$32.5M
Gross Margin
65.7%
Operating Margin
3.1%
-19.7%
Net Margin
3.5%
37.3%
Revenue YoY
12.7%
-1.2%
Net Profit YoY
129.7%
180.8%
EPS (diluted)
$0.07
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PHR
PHR
SDGR
SDGR
Q4 25
$120.3M
$87.2M
Q3 25
$117.3M
$54.3M
Q2 25
$115.9M
$54.8M
Q1 25
$59.6M
Q4 24
$88.3M
Q3 24
$35.3M
Q2 24
$47.3M
Q1 24
$36.6M
Net Profit
PHR
PHR
SDGR
SDGR
Q4 25
$4.3M
$32.5M
Q3 25
$654.0K
$-32.8M
Q2 25
$-3.9M
$-43.2M
Q1 25
$-59.8M
Q4 24
$-40.2M
Q3 24
$-38.1M
Q2 24
$-54.0M
Q1 24
$-54.7M
Gross Margin
PHR
PHR
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
PHR
PHR
SDGR
SDGR
Q4 25
3.1%
-19.7%
Q3 25
-1.3%
-84.6%
Q2 25
-2.8%
-96.6%
Q1 25
-85.5%
Q4 24
-23.5%
Q3 24
-193.9%
Q2 24
-111.4%
Q1 24
-184.3%
Net Margin
PHR
PHR
SDGR
SDGR
Q4 25
3.5%
37.3%
Q3 25
0.6%
-60.4%
Q2 25
-3.4%
-78.8%
Q1 25
-100.4%
Q4 24
-45.5%
Q3 24
-108.1%
Q2 24
-114.2%
Q1 24
-149.5%
EPS (diluted)
PHR
PHR
SDGR
SDGR
Q4 25
$0.07
$0.45
Q3 25
$0.01
$-0.45
Q2 25
$-0.07
$-0.59
Q1 25
$-0.82
Q4 24
$-0.55
Q3 24
$-0.52
Q2 24
$-0.74
Q1 24
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PHR
PHR
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$106.4M
$395.5M
Total DebtLower is stronger
$3.4M
Stockholders' EquityBook value
$320.3M
$364.1M
Total Assets
$423.5M
$726.2M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PHR
PHR
SDGR
SDGR
Q4 25
$106.4M
$395.5M
Q3 25
$98.3M
$391.2M
Q2 25
$90.9M
$450.2M
Q1 25
$500.3M
Q4 24
$352.1M
Q3 24
$388.7M
Q2 24
$377.3M
Q1 24
$431.1M
Total Debt
PHR
PHR
SDGR
SDGR
Q4 25
$3.4M
Q3 25
$4.6M
Q2 25
$6.2M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PHR
PHR
SDGR
SDGR
Q4 25
$320.3M
$364.1M
Q3 25
$298.0M
$321.4M
Q2 25
$282.2M
$342.9M
Q1 25
$373.5M
Q4 24
$421.4M
Q3 24
$449.4M
Q2 24
$474.0M
Q1 24
$513.7M
Total Assets
PHR
PHR
SDGR
SDGR
Q4 25
$423.5M
$726.2M
Q3 25
$408.6M
$653.7M
Q2 25
$400.4M
$688.2M
Q1 25
$743.0M
Q4 24
$823.2M
Q3 24
$669.3M
Q2 24
$688.4M
Q1 24
$737.8M
Debt / Equity
PHR
PHR
SDGR
SDGR
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PHR
PHR
SDGR
SDGR
Operating Cash FlowLast quarter
$15.5M
$-16.1M
Free Cash FlowOCF − Capex
$12.2M
$-16.1M
FCF MarginFCF / Revenue
10.1%
-18.5%
Capex IntensityCapex / Revenue
2.7%
0.0%
Cash ConversionOCF / Net Profit
3.62×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PHR
PHR
SDGR
SDGR
Q4 25
$15.5M
$-16.1M
Q3 25
$14.8M
$-61.9M
Q2 25
$14.8M
$-52.2M
Q1 25
$144.1M
Q4 24
$-31.1M
Q3 24
$-33.3M
Q2 24
$-53.7M
Q1 24
$-39.3M
Free Cash Flow
PHR
PHR
SDGR
SDGR
Q4 25
$12.2M
$-16.1M
Q3 25
$13.1M
$-62.4M
Q2 25
$11.3M
$-52.5M
Q1 25
$143.5M
Q4 24
$-32.0M
Q3 24
$-34.6M
Q2 24
$-54.7M
Q1 24
$-43.4M
FCF Margin
PHR
PHR
SDGR
SDGR
Q4 25
10.1%
-18.5%
Q3 25
11.1%
-114.8%
Q2 25
9.8%
-95.9%
Q1 25
240.9%
Q4 24
-36.2%
Q3 24
-98.0%
Q2 24
-115.6%
Q1 24
-118.5%
Capex Intensity
PHR
PHR
SDGR
SDGR
Q4 25
2.7%
0.0%
Q3 25
1.5%
0.9%
Q2 25
3.0%
0.6%
Q1 25
1.0%
Q4 24
1.0%
Q3 24
3.8%
Q2 24
2.1%
Q1 24
11.2%
Cash Conversion
PHR
PHR
SDGR
SDGR
Q4 25
3.62×
-0.50×
Q3 25
22.68×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PHR
PHR

Subscription And Services$55.5M46%
Network Solutions$37.4M31%
Payment Processing Fees$27.4M23%

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons